Nonhepatic manifestations and combined diseases in HCV infection

Digestive Diseases and Sciences

Volumn 41, Issue 12 SUPPL., 1996, Pages

  Hadziyannis, Stephanos J ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

hepatitis C virus; idiopathic thrombocytopenia; interferon; mixed cryoglobulinemia; non Hodgkin's lymphoma; porphyria cutanea tarda; thyroid diseases

Indexed keywords

ALPHA INTERFERON;

CONFERENCE PAPER; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; LICHEN PLANUS; NONHODGKIN LYMPHOMA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; SALIVARY GLAND DISEASE; SKIN DISEASE; THROMBOCYTOPENIA; THYROID DISEASE; VIRUS REPLICATION;

EID: 0030481065     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02087878     Document Type: Conference Paper

References (154)

1. Koff RS, Dienstag JL: Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease. Semin Liver Dis 15:101-109, 1995
2. Nowicki MJ, Balisteri WF: The hepatitis C virus: Identification, epidemiology, and clinical controversies. J Pediatr Gastroenterol Nutr 20:248-274, 1995
3. Gumber SC, Chopra S: Hepatitis C: A multifaced disease. Review of extrahepatic manifestations. Ann Intern Med 123:615-620, 1995
4. Berris B, Feinman SV: Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis. Dig Dis Sci 36:1657-1660, 1991
5. Lisker-Melman M, Di Bisceglie AM, Usala SJ, Weintraub B, Murray LM, Hoofnagle JH: Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha. Gastroenterology 102:2155-2160, 1992
6. Baudin E, Marcellin P, Pouteau M, Colas-Linhart N, Le Floch J-P, Lemonnier C, Benhamou J-P, Bok B: Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin Endocrinol 39:657-661, 1993
7. Marcellin P, Pouteau M, Renard P, Grynblat J-M, Colas Linhart N, Bardet P, Bok B, Benhamou J-P: Sustained hypothyroidism induced by recombinant α interferon in patients with chronic hepatitis C. Gut 33:855-856, 1992
8. Tran A, Quaranta J-F, Benzaken S, Thiers V, Chau HT, Hastier P, Regnier D, Dreyfus G, Pradier C, Sadoul J-L, Hebuterne X, Rampal P: High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 18:253-257, 1993
9. Tran A, Quaranta JF, Beusnel C, Thiers V, De Souza M, Francois E, Hebuterne X, Rampal P: Hepatitis C virus and Hasimoto's thyroiditis. Eur J Med 1:116-118, 1992
10. Duclos-Vallee JC, Johanet C, Duron F, Pateron D, Homberg JC, Beaugrand M: High prevalence of anti-HCV antibodies in patients with Hashimoto's thyroiditis. J Hepatol 16(suppl 1):S56, 1992
11. Pateron D, Hartmann DJ, Duclos-Vallee JC, Jouanolle H, Beaugrand M: Latent autoimmune thyroid disease in patients with chronic HCV hepatitis. J Hepatol 16:244-245, 1992 (letter)
12. Quaranta J-F, Tran A, Régnier D, Lestestu R, Beusnel C, Fuzibet JG, Thiers V, Rampal P: High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoantibodies. J Hepatol 18:136-138, 1993 (letter)
13. Pawlotsky J-M, Yahia MB, Andre C, Voisin M-C, Intrator L, Roudot-Thoraval F, Duvoux C, Zafrani E-S, Duval J, Dhumeaux D: Immunological disorders in C virus chronic active hepatitis: A prospective case-control study. Hepatology 19:841-848, 1994
14. Alison MED, Wreghitt T, Palmer CR, Alexander GJM: Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 21:1135-1139, 1994
15. Uzunalimoglu Ö, Sipahi N, Dokmeci A, Özden A, Sümer N, Kesim E, Cetinkaya H, Dönderici O, Karayalçin S, Yurdaydin C: A link between hepatitis C infection and diabetes mellitus in a Mediterranean population. J Hepatol 23(suppl 1):179, 1995 (abstract)
16. Haddad J, Deny P, Munz-Gotheil C, Ambrosini J-C, Trinchet J-C, Pateron D, Mal F, Callard P, Beaugrand M: Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339:321-323, 1992
17. Pirisi M, Scott C, Fabris C, Ferraccioli G, Soardo G, Ricci R, Toniutto P, Avellini C, Vitulli D, Miotti AM, Beltrami CA, Bartoli E: Mild sialoadenitis: A common finding in patients with hepatitis C virus infection. Scand J Gastroenterol 29:940-942, 1994
18. Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA: Mooren's corneal ulcers and hepatitis C virus infection, N Engl J Med 329:62, 1993 (letter)
19. Wilson SE, Lee WM, Murakami C, Weng J, Moninger GA: Mooren-type hepatitis C virus-associated corneal ulceration. Ophthalmology 101:736-745, 1994
20. Grateau G, Bachmeyer C, Malek N, Jublanc C, Caputo G, Renard G: Mooren-type hepatitis C virus-associated cortical ulceration. Eur J Intern Med 6(suppl 1):24, 1995 (abstract)
21. Disdier P, Bolla G, Veit V, Ridings B, Gambarelli-Mouillac N, Harle JR, Weiller PJ: Association of uveitis and hepatitis C: 5 cases. Presse Med 23:541, 1994 (letter) (in French)
22. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Mazzoni A, Pasero G, Bombardieri S, Highfield P, Corbishley T: Association between hepatitis C virus and mixed cryoglobulinemia, Clin Exp Rheumatol 9:621-624, 1991
23. Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490-1495, 1992
24. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, Vendramin G, Comotti B, Tanzi E, Scudeller G, Zanetti A: Hepatitis C virus infection in patients with essential mixed cryoglobulinemia, Ann Intern Med 117:573-577, 1992
25. Dammacco F, Sansonno D: Antibodies to hepatitis C virus in essential mixed cryoglobulinemia, Clin Exp Immunol 87:352-356, 1992
26. Hibbs JR, Issaragrisil S, Young NS: High prevalence of hepatitis C viremia among aplastic anemia patients and controls from Thailand. Am J Trop Med Hyg 46:564-570, 1992
27. Gruber A, Grillner L, Norder H, Magnius L, Björkholm M: Severe aplastic anemia associated with seronegative community-acquired hepatitis C virus infection, Ann Hematol 66:157-159, 1993
28. Durand JM, Lefevre P, Telle H, Kaplanski G, Quiles N, Soubeyrand J: Thrombocytopenic purpura and hepatitis C virus infection. Hematologia 78:135, 1993 (letter)
29. Durand JM, Cretel E, Retornaz F, Lefevre P, Kaplanski G, Soubeyrand J: Alpha interferon therapy in thrombocytopenia associated with hepatitis C virus infection. J Hepatol 21:277-278, 1994 (letter)
30. Ferri C, Monti M, La Civita L, Careccia G, Mazzaro C, Longombardo G, Lombardini F, Greco F, Pasero G, Bonbardieri S, Zignego AL: Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinemia. Eur J Clin Invest 24:781-784, 1994
31. Zignego AL, Ferri C, Giannini C, Caracciolo F, Monti M, La Civita L, Careccia G, Longombardo G, Ballesi G, Innocenti F, Thiers V, Gentilini P: HCV infectin in B-cell non-Hodgkin's lymphoma. J Hepatol 23(suppl 1):77, 1995 (abstract)
32. Franzin F, Ebremov D, Pozzato G, Pussini E, Tulissi P, Burrone O: Monoclonal B-cell expansion, non-Hodgkin's lymphomas and HCV infection. J Hepatol 23(suppl 1):89, 1995 (abstract)
33. Rollino C, Roccatello D, Giachino O, Basolo B, Piccoli G: Hepatitis C virus infection and membranous glomerulonephritis. Nephron 59:319-320, 1991
34. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Covey L, Wener MH, Alpers CE, Willson R: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 328:465-470, 1993
35. Burstein DM, Rodby RA: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. J Am Soc Nephrol 4:1288-1293, 1993
36. Arai H, Tanaka M, Ohta K, Kojo T, Niijima K, Imawari M: Symptomatic myopathy associated with interferon therapy for chronic hepatitis C, Lancet 345:582, 1995 (letter)
37. Dale JK, Di Bisceglie AM, Hoffnagle JH, Straus SE: Chronic fatigue syndrome: Lack of association with hepatitis C virus infection. J Med Virol 34:119-121, 1991
38. Horsmans Y, Geubel AP: Symptomatic myopathy in hepatitis C infection without interferon therapy, Lancet 345:1236, 1995 (letter)
39. Sawada T, Hirohata S, Inoue T, Ito K: Development of rheumatoid arthritis after hepatitis C virus infection. Arthritis Rheum 34:1620-1621, 1991
40. Borque L, Elena A, Maside C, Rus A, Del Cura J: Rheumatoid arthritis and hepatitis C virus antibodies. Clin Exp Rheumatol 9:617-619, 1991
41. Durand JM, Lefevre P, Harle JR, Boucrat J, Vitvitski L, Soubeyrand J: Cutaneous vasculitis and cryoglobulinemia type II associated with hepatitis C virus infection. Lancet 337:449-500, 1991 (letter)
42. Pakula AS, Garden JM, Roth SI: Cryoglobulinemia and cutaneous leukocytoclastic vasculitis associated with hepatitis C virus infection. J Am Acad Dermatol 28:850-853, 1993
43. Daoud MS, Gibson LE, Daoud S, el-Azhary RA: Chronic hepatitis C and skin diseases: A review. Mayo Clin Proc 70:559-564, 1995
44. Fargion S, Piperno A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, Caldarelli R, Marcelli R, Vecchi L, Fiorelli G: Hepatitis C virus and porphyria cutanea tarda: Evidence of a strong association. Hepatology 16:1322-1326, 1992
45. DeCastro M, Sánchez J, Herrera JF, Cháves A, Durán R, García-Buey L, García-Monzón C, Sequí J, Moreno-Otero R: Hepatitis C virus antibodies and liver disease in patients with porphyria cutanea tarda. Hepatology 17:551-557, 1993
46. Mokni M, Rybojad M, Puppin D Jr, Catala S, Venezia F, Djian R, Morel P: Lichen planus and hepatitis C virus. J Am Acad Dermatol 24:792, 1991
47. Agner T, Fogh H, Weismann K: The relation between lichen planus and hepatitis C: A case report. Acta Derm Venereol 72:380, 1992
48. Santander C, DeCastro M, García-Monzón C, García-Buey L, Sanchez J, Herera JF, Borque MJ, Moreno-Otero R: Prevalence of hepatitis C virus (HCV) infection and liver damage in patients with lichen planus (LP). Hepatology 20(4 Pt 2):238A, 1994 (abstract)
49. Antinori S, Esposito R, Aliprandi CA, Tadini G: Erythema multiforme and hepatitis C. Lancet 337:428, 1991 (letter)
50. Domingo P, Ris J, Martinez E, Casas F: Erythema nodosum and hepatitis C. Lancet 336:1377, 1990 (letter)
51. Bodokh I, Lacour JP, Perrin C, Rainero C, Lebreton E, Grosshan E, Ortonne JP: Cutaneous malacoplakia associated with chronic hepatitis caused by hepatitis C virus. Ann Dermatol Venereol 120:808-810, 1993
52. Reichel M, Mauro TM: Urticaria and hepatitis C. Lancet 336:822-823, 1990 (letter)
53. Fisher DA, Wright TL: Pruritus as a symptom of hepatitis C. J Am Acad Dermatol 30:629-632, 1994
54. Quint L, Deny P, Guillevin L, Granger B, Jarrousse B, Lhote F, Scavizzi M: Hepatitis C virus in patients with polyarteritis nodosa. Prevalence in 38 patients. Clin Exp Rheumatol 9:253-257, 1991
55. Cacoub P, Lunel-Fabiani F, Du LTH: Polyarteritis nodosa and hepatitis C virus infection. Ann Intern Med 116:605-606, 1992 (letter)
56. Carson CW, Conn DL, Czaja AJ, Wright TL, Brecher ME: Freuqency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 20:304-309, 1992
57. Ueda T, Ohta K, Suzuki N, Yamaguchi M, Hirai K, Horiuchi T, Wantanbe J, Miyamoto T, Ito KF: Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus. Am Rev Respir Dis 146:266-268, 1992
58. Bianchi FB: Autoimmune hepatitis: The lesson of the discovery of hepatitis C virus. J Hepatol 18:273-275, 1993
59. Maddrey WC: How many types of autoimmune hepatitis are there? Gastroenterology 105:1571-1575, 1993
60. Vergani D, Mieli-Vergani G: Type II autoimmune hepatitis. What is the role of the hepatitis C virus? Gastroenterology 104:1870-1873, 1993
61. Czaja AJ: Autoimmune hepatitis and viral infection. Gastroenterol Clin North Am 23:547-566, 1994
62. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, Bronkovsky HL: High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21:613-619, 1995
63. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, Alberti A: Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 105:1529-1533, 1993
64. Feray C, Gigou M, Samuel D, Reyes G, Bernuau J, Reynes M, Bismuth H, Brechot C: Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 104:549-555, 1993
65. Kaklamani E, Trichopoulos D, Tzonou A, Zavitsanos X, Karmantaki Y, Hatzakis A, Hsieh CC, Hadziyannis S: Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 265:1974-1976, 1991
66. Hadziyannis SJ, Giannoulis G, Hadziyannis E, Kaklamani E, Alexopoulou A, Dourakis S, Trichopoulos D: Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma. J Hepatol 17(suppl 3):S72-S77, 1993
67. Hadziyannis S, Wages J, Kim JP, Karayiannis P, Hess G, Piatak M, Lifson J, Vrettou H, Horsch A, Foung S, Thomas HC: Frequency of viremia with a new hepatitis virus (HGV) in patients with liver disease and in groups at high risk of exposure to blood and blood products. J Hepatol 23(suppl 1):78, 1995 (abstract)
68. Hadziyannis SJ, Dawson GJ, Vrettou E, Gioustozi A, Schlauder G, Desai S: Infection with the novel GB-C virus in multiply transfused patients and in various forms of chronic liver disease. Hepatology 22(4 Pt 2):218A, 1995 (abstract)
69. Hayashi PH, Flynn N, McCurdy SA, Kuramoto IK, Holland PV, Zeldis JB: Prevalence of hepatitis C virus antibodies among patients infected with human immunodeficiency virus. J Med Virol 33:177-180, 1991
70. McNair ANB, Main J, Thomas HC: interactions of the human immunodeficiency virus and the hepatotropic viruses. Semin Liver Dis 12:188-196, 1992
71. Wright TL, Hollander H, Pu X, Held MJ, Lipson P, Quan S, Polito A, Thaler MM, Bacchetti P, Scharschmidt BF: Hepatitis C in HIV-infected patients with and without AIDS: Prevalence and relationship to patient survival. Hepatology 20:1152-1155, 1994
72. Guido M, Rugge M, Fattovich G, Rocchetto P, Cassaro M, Chemello L, Noventa F, Giustina G, Alberti A: Human immunodeficiency virus infection and hepatitis C pathology. Liver 14:314-319, 1994
73. Abeck D, Brandt O, Weichenthal M, Kowalzick L, Mensing H: Chronic mucocutaneous herpes simplex infection. Occurrence within the scope of liver-induced immunodeficiency. Hautarzt 44:670-673, 1993 (in German)
74. Kamel MA, Miller FD, el Masry AG, Zakaria S, Khattab M, Essmat G, Ghaffar YA: The epidemiology of schistosoma mansoni, hepatitis B and hepatitis C infection in Egypt. Ann Trop Med Parasitol 88:501-509, 1994
75. Koshy A, al-Nakib B, al-Mufti S, Madda JP, Hira PR: Anti-HCV-positive cirrhosis associated with schistosomiasis. Am J Gastroenterol 88:1428-1431, 1993
76. Mendenhall CL, Seeff L, Diehl AM, Ghosn SJ, French SW, Gartside PS, Rouster SD, Buskell-Bales Z, Grossman CJ, Roselle GA, Weesner RE, Garcia-Pont P, Goldberg SJ, Kiernan TW, Tamburro CH, Zetterman R, Chedid A, Chen T, Rahin L, and the VA cooperative study group (no. 119): Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: Their prevalence and clinical relevance. Hepatology 14:581-589, 1991
77. Fong T-L, Kanel GC, Conrad A, Valinluck B, Charboneau F, Adkins RH: Clinical significance of concomitant hepatitis C infection in patients with alcoholic liver disease. Hepatology 19:554-557, 1994
78. Zignego AL, Foschi M, Laffi G, Monti M, Careccia G, Romanelli RG, De Majo E, Mazzanti R, Buzzelli G, La Villa G, Gentilini P: "Inapparent" hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease. Hepatology 19:577-582, 1994
79. Yokoyama H, Ishii H, Moriya S, Nagata S, Watanabe T, Kamegaya K, Takahashi H, Maruyama K, Haber P, Tsuchiya M: Relationship between hepatitis C virus subtypes and clinical features of liver disease seen in alcoholics. J Hepatol 22:130-134, 1995
80. von Weizsacker F, Maeda E, Brown N, Poynard T, Galun E, Labeit S, Caput J-C, Arima T, Blum II, Wands JR: Hepatitis B and C virus infection in HBsAg-negative alcoholics without i.v. drug abuse or previous blood transfusions. Int Hepatol Commun 4/2:80-87, 1995
81. van den Hock JAR, van Haastrecht HJA, Goudsmit J, de Wolf F, Coutinho RA: Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 162:823-826, 1990
82. Tibbs CJ: Methods of transmission of hepatitis C. J Viral Hepatitis 2:113-119, 1995
83. Rodriguez M, Riestra S, San Roman F, Navascues CA, Suarez A, Perez R, Lombrana JL, Rodrigo L: Prevalence of antibody to hepatitis C virus in acute non-A, non-B hepatitis in patients from different epidemiological categories. Arch Virol 4(suppl):319-320, 1992
84. Olynyk JK, Rajender Reddy K, Di Bisceglie AM, Jeffers LJ, Parker TI, Radick JL, Schiff ER, Bacon BR: Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 108:1104-1109, 1995
85. Barton AL, Banner BF, Cable EE, Bonkovsky HL: Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy. Am J Clin Pathol 103:419-424, 1995
86. Farinati F, Cardin R, De Maria N, Delia Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R: Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 22:449-456, 1995
87. Zeldis JB, Depner TA, Kuramoto IK, Gish RG, Holland PV: The prevalence of hepatitis C virus antibodies among hemodialysis patients. Ann Intern Med 112:958-960, 1990
88. Sakamoto N, Enomoto N, Marumo F, Sato C: Prevalence of hepatitis C virus infection among long-term hemodialysis patients: Detection of hepatitis C virus RNA in plasma. J Med Virol 39:11-15, 1993
89. Okuda K, Hayashi H, Kobayashi S, Irie Y: Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients. J Hepatol 23:28-31, 1995
90. Hou C-H, Chen W-Y, Kao J-H, Chen D-S, Yang Y, Chen J-J, Lee S-H, Wu D-J, Yang S-C: Intrafamilial transmission of hepatitis C virus in hemodialysis patients. J Med Virol 45:381-385, 1995
91. Mangia A, Cascavilla L, Musto P, Clemente R, Carotenuto M, Rizzetto M, Andriulli A: Hepatitis C virus infection in patients with monoclonal gammopathy. J Hepatol 23(suppl 1):188, 1995 (abstract)
92. Rodriquez-Rosado R, Belogui O, Fernandez J, Inoges S, Prieto J: Detection of anticardiolipin antibodies and β-2-GPI in cryoprecipitate of patients with chronic hepatitis C and cryoglobulinemia. J Hepatol 23(suppl 1):95, 1995 (abstract)
93. Holló G, Szalay F, Nemesánszky H: Dry eye syndrome in chronic hepatic diseases. J Hepatol 23(suppl 1):250, 1995 (abstract)
94. Perez-Calvo, Torralba MA, Cebollada J, Morandeira MJ, Otal I, Barrao F: Chronic C hepatitis and coincidental liver granulomatosis. Eur J Intern Med 6(suppl 1):13, 1995 (abstract)
95. Huang M-J, Liaw Y-F: Clinical associations between thyroid and liver diseases. J Gastroenterol Hepatol 10:344-350, 1995
96. Golding PL, Smith M, Williams R: Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis. Am J Med 55:772-782, 1973
97. Crowe JP, Christensen E, Buttler J, Wheeler P, Doniach D, Keenan J, Williams R: Primary biliary cirrhosis: The prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology 78:1437-1441, 1980
98. Huang MJ, Chien RN, Tsai SL, Liaw YF: High prevalence of thyroid autoantibodies in patients with chronic hepatitis C. Int Hepatol Commun 3(suppl):S50, 1995
99. Marcellin P, Pouteau M, Benhamou J-P: Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction. J Hepatol 22:364-369, 1995
100. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH: Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 321:1506-1510, 1989
101. Kodama T, Katabami S, Kamijo K, Katanuma A, Yamashita K, Azuma N, Tamaki T, Yachi A: Development of transient thyroid disease and reaction during treatment of chronic hepatitis C with interferon. J Gastroenterol 29:289-292, 1994
102. Boadas J, Rodríguez-Espinosa J, Enríquez J, Miralles F, Martínez-Cerezo FJ. González P, Madoz P, Vilardell F: Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection. J Hepatol 22:611-615, 1995
103. Watanabe U, Hashimoto E, Hisamitsu T, Obata H, Hayashi N: The risk factor for development of thyroid disease during interferon-α therapy for chronic hepatitis C. Am J Gastroenterol 89:399-403, 1994
104. Wang J-T, Want T-H, Sheu J-C, Lin J-T, Chen D-S: Hepatitis C virus RNA in saliva of patients with posttransfusion hepatitis and low efficiency of transmission among spouses. J Med Virol 36:28-31, 1992
105. Mariette X, Loiseau P, Morinet F: Hepatitis C virus in saliva. Ann Intern Med 122:556, 1995 (letter)
106. King PD, McMurray RW, Becherer PR: Sjögren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection. Am J Gastroenterol 89:1047-1050, 1994
107. Bouffard P, Hayashi PH, Acevedo R, Levy N, Zeldis JB: Hepatitis C virus is detected in a monocyte/macrophage sub-population of peripheral blood mononuclear cells of infected patients. J Infect Dis 166:1276-1280, 1992
108. Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G, Gentilini P, Bombardieri S, Zignego AL: Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 82:3701-3704, 1993
109. Agnello V, Abel G, Knight GB, Monteverde A, Ballare M, Bertoncelli MC, Pileri SA, Hitchcock L: Detection of hepatitis C virus (HCV) in liver, bone marrow, and lymph nodes in type II mixed cryoglobulinemia (MC) using in situ hybridization. Fifth International Symposium on Hepatitis C Virus and Related Viruses. Gold Coast, Australia, 1995, C163 (abstract)
110. Abel G, Knight GB, Agnello V: Hepatitis C virus (HCV) infection of keratinocytes of vasculitis lesions in type II cryoglobulinemia (MC). Fifth International Symposium on Hepatitis C Virus and Related Viruses. Gold Coast, Australia, 1995, C152 (abstract)
111. Freni MA, Artuso D, Gerken G, Spanti C, Marafioti T, Alessi N, Spadaro A, Ajello A, Ferrau O: Focal lymphocytic aggregates in chronic hepatitis C: occurrence, immunohistochemical characterization, and relation to markers of autoimmunity. Hepatology 22:389-394, 1995
112. Meltzer M, Franklin EC: Cryoglobulinemia - a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med 40:828-836, 1966
113. Ferri C, Monti M, Lo Jacono F, Caracciolo F, La Civita L, Careccia G, Longombardo G, Giannini C, Greco F, Mazzoni A, Ceccherini-Nelli L, Zignego AL: Infection by HCV and other lymphotropic viruses in B-cell non-Hodgkin's lymphoma. J Hepatol 23(suppl 1):98, 1995 (abstract)
114. Hartmann H, Schott P, Polzien F, Mihm S, Ramadori G: Cryoglobulinemia in chronic hepatitis C virus infection: Is cross-reactivity of anti-HCV IgM to IgG a pathogenetic mechanism? J Hepatol 23(suppl 1):80, 1995 (abstract)
115. Levo Y, Gorevic PD, Kassab HJ, Tobias H, Franklin EC: Liver involvement in the syndrome of mixed cryoglobulinemia. Ann Intern Med 87:287-292, 1977
116. Hijikata M, Shimizu YK, Kato H, Iwamoto A, Shih JW, Alter HJ, Purcell RH, Yoshikura H: Equilibrium centrifugation studies of hepatitis C virus: Evidence for circulating immune complexes. J Virol 67:1953-1958, 1993
117. Casato M, Taliani G, Pucillo LP, Goffredo F, Lagana B, Bononio L: Cryoglobulinemia and hepatitis C virus. Lancet 337:1047-1048, 1991
118. Pascual M, Perrin L, Giostra E, Schifferli JA: Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 162:569-570, 1990 (letter)
119. Marcellin P, Descamps V, Martinot-Peignoux M, Larque D, Xu L, Boyer N, Pharm B-N, Crickx B, Guillevin L, Belaich S, Erlinger S, Benhamou J-P: Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology 104:272-277, 1993
120. Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, Hoang C, Piette JC, Huraux J-M, Opolon P: Cryoglobulinemia in chronic liver diseases: Role of hepatitis C virus and liver damage. Gastroenterology 106:1291-1300, 1994
121. Kakumu S, Alyama T, Yoshioka K, Okumura A, Takayanagi M, Iwata K, Yamada M: Cryoglobulinemia and chronic hepatitis C virus disease among Japanese patients. Int Hepatol Commun 3(suppl):S49, 1995
122. Cacoub P, Frangeul L, Lunel F, Musset L, Piette J-C, Opolon P, Huraux J-M, Godeau P, Poynard T: Mixed cryoglobulinemia and hepatitis C virus infection: A multivariate analysis. Arth Rheum 38(suppl 9):S199, 1995
123. Schirren CA, Zachoval R, Schirren CG, Gerbes AL, Pape GR: A role for chronic hepatitis C virus infection in a patient with cutaneous vasculitis, cryoglobulinemia, and chronic liver disease. Dig Dis Sci 40:1221-1225, 1995
124. Zenda T, Okamoto R, Sanada H, Okada T, Masunaga T, Takeda Y, Takeda R, Nonomura A, Funaki N: A possible pathogenic relation between hepatitis C virus and essential cryoglobulinemia, rheumatoid factor and consumption of complement following interferon-beta therapy for chronic active hepatitis C. Acta Hepatol Japon 36:381-385, 1995
125. Martins A, Goncalves G, Costa A, Ribeiro S, Reis A: Mixed cryoglobulinemia type III associated to chronic hepatitis C virus infection. Eur J Intern Med 6(suppl 1):71, 1995 (abstract)
126. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Suroni PL, Zilio P, Vernocchi A, Massazza M, Vendramin G, Tanzi E, Zanetti A: Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751-756, 1994
127. Bordin G, Ballare M, Bertoncelli MC, Paccagnino L, Zigrossi P, Monteverde A: HCV-associated thrombocytopenia, thrombokinetic study. Fifth International Symposium on Hepatitis C Virus and Related Viruses. Gold Coast, Australia, 1995, C151 (abstract)
128. Theilmann L, Gmelin K, Kallinowski B, Kommerell B, Koderisch J, Andrassy K: Prevalence of antibodies to hepatitis C virus in sera from patients with systemic necrotizing vasculitis. Nephron 57:482, 1991 (letter)
129. Hearth-Holmes M, Zahradka S, Baethge BA, Wolf RE: Leukocytoclastic vasculitis associated with hepatitis C. Am J Med 90:765-766, 1991 (letter)
130. Rémond B, Reygagne P, Aractingi S, Dubertrer L: Vascularite cutanée avec cryoglobulinémie mixte au cours d'une hépatite chronique C. Ann Dermatol Venereol 119:827-829, 1992
131. Durand JM, Kaplanski G, Richard MA, Lefevre P, Quiles N, Trepo C, Soubeyrand J: Cutaneous vasculitis in a patient infected with hepatitis C virus. Detection of hepatitis C virus RNA in the skin by polymerase chain reaction. Br J Dermatol 128:359-360, 1993 (letter)
132. Zimmermann R, König V, Bauditz J, Hopf U: Interferon alfa in leukocytoclastic vasculitis, mixed cryoglobulinemia, and chronic hepatitis C. Lancet 341:561-562 (letter)
133. Levey JM, Bjornsson B, Banner B, Kuhns M, Malhotra R, Whitman N, Romain PL, Cropley TG, Bonkovsky HL: Mixed cryoglobulinemia in chronic hepatitis C infection. A clinicopathologic analysis of 10 cases and review of recent literature, Medicine 73:53-67, 1994
134. Ferri C, Baicchi U, La Civita L, Greco F, Longombardo G, Mazzoni A, Careccia G, Bombardieri S, Pasero G, Zignego AL, Manns MP: Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. Eur J Clin Invest 23:851-855, 1993
135. Herrero C, Vicente A, Bruguera M, Ercilla MG, Barrera JM, Vidal J, Terés J, Mascaró JM, Rodés J: Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet 341:788-789, 1993
136. Lacour JPL, Bodokh I, Castanet J, Beckri S, Ortonne JP: Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 128:121-123, 1993
137. Koester G, Feldman J, Bigler C: Hepatitis C in patients with porphyria cutanea tarda. J Am Acad Dermatol 31:1054, 1994
138. Stölzel U, Köstler E, Stöffler-Meilicke M, Somasundaram R, Frohburg U, Doss MO, Riecken EO: Hepatitis C virus infection in porphyria cutanea tarda in Germany. Gastroenterology 106:A990, 1994
139. Navas S, Bosch O, Castillo I, Marriott E, Carreño V: Porphyria cutanea tarda and hepatitis C and B viruses infection: A retrospective study. Hepatology 21:279-284, 1995
140. Kondo M, Horie V, Okano J, Kawasaki U, Mishiro S, Yamamoto S, Okamoto H: Porphyria cutanea tarda and HCV infection. Int Hepatol Commun 3(suppl):S45, 1995
141. Rebora A, Rongioletti F: Lichen planus and chronic active hepatitis. A retrospective survey. Acta Derm Venereol 64:52-56, 1984
142. Doutre MS, Beylot C, Couzigou P, Long P, Royer P, Beylot J: Lichen planus and virus C hepatitis: Disappearance of the lichen under interferon alfa therapy. Dermatology 184:229, 1992 (letter)
143. Strumia R, Venturini D, Boccia S, Gamberini S, Gullini S: UVA and interferon-alfa therapy in a patient with lichen planus and chronic hepatitis C. Int J Dermatol 32:386, 1993 (letter)
144. Boccia S, Gamberini S, Dalla Libera M, Strumia R, Venturini D: Lichen planus and interferon therapy for hepatitis C. Gastroenterology 105:1921-1922, 1993 (letter)
145. Cecchi R, Giomi A, Tuci F, Bartoli L, Seghieri G: Pityriasis rubra pilaris, lichen planus, alopecia universalis and vitiligo in a patient with chronic viral hepatitis C. Dermatology 188:239-240, 1944
146. Papini M, Bruni PL, Bettacchi A, Liberati F: Sudden onset of oral ulcerative lichen in a patient with chronic hepatitis C on treatment with alfa-interferon. Int J Dermatol 33:221-222, 1994 (letter)
147. Protzer U, Ochsendorf FR, Leopolder-Ochsendorf A, Holtermüller K-H: Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C. Gastroenterology 104:903-905, 1993
148. Barreca T, Corsini G, Franceschini R, Gambini C, Garibaldi A, Rolandi E: Lichen planus induced by interferon-alpha-2a therapy for chronic active hepatitis C. Eur J Gastroenterol Hepatol 7:367-368, 1995
149. Rebora A, Robert E, Rongioletti F: Clinical and laboratory presentation of lichen planus patients with chronic liver disease. J Dermatol Sci 4:38-41, 1992
150. Divano MC, Parodi A, Rebora A: Lichen planus, liver kidney microsomal (LKM1 ) antibodies and hepatitis C virus antibodies. Dermatology 185:132-133, 1992
151. Gundolfo S, Carbone M, Carozzo M, Gallo V: Oral lichen planus and hepatitis C virus (HCV) infection: Is there a relationship? A report of 10 cases. J Oral Pathol Med 23:119-122, 1994
152. Jubert C, Pawlotsky J-M, Pouget F, Andre C, DeForges L, Bretagne S, Mavier J-P, Duval J, Revuz J, Dhumeaux D, Bagot M: Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 130:73-76, 1994
153. Manns MP, Griffin KJ, Sullivan KF, Johnson EF: LKM-1 autoantibodies recognize a short linear seuqence in p450IID6, a cytochrome P-450 monoxygenase. J Clin Invest 88:1370-1378, 1991
154. Abuaf N, Lunel F, Giral P, Borotto E, Laperche S, Poupon R, Opolon P, Huraux J-M, Homberg JC: Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol 18:359-364, 1993